Trial Profile
A Single-Dose, Bioequivalence Study of 105 mg Fenofibric Acid Tablets Versus 145 mg TriCor (Fenofibrate) Tablets Under Fasting Conditions.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Fenofibric-acid (Primary) ; Fenofibrate
- Indications Hypercholesterolaemia; Hypertriglyceridaemia
- Focus Pharmacokinetics
- Sponsors URL Pharma
- 01 Jun 2011 Results published in the Clinical Therapeutics.
- 26 Aug 2009 New trial record